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Surgical Ablation of Atrial Fibrillation Using 
Energy Sources
Alexandre Visconti Brick1, MD, MSc; Domingo Marcolino Braile2, MD, PhD
Abstract 
Surgical ablation, concomitant with other operations, is an option 
for treatment in patients with chronic atrial fibrillation. The aim of 
this study is to present a literature review on surgical ablation of 
atrial fibrillation in patients undergoing cardiac surgery, considering 
energy sources and return to sinus rhythm. A comprehensive 
survey was performed in the literature on surgical ablation of atrial 
fibrillation considering energy sources, sample size, study type, 
outcome (early and late), and return to sinus rhythm. Analyzing 
studies with immediate results (n=5), the percentage of return to 
sinus rhythm ranged from 73% to 96%, while those with long-term 
results (n=20) (from 12 months on) ranged from 62% to 97.7%. In 
both of them, there was subsequent clinical improvement of patients 
who underwent ablation, regardless of the energy source used. 
Surgical ablation of atrial fibrillation is essential for the treatment 
of this arrhythmia. With current technology, it may be minimally 
invasive, making it mandatory to perform a procedure in an attempt 
to revert to sinus rhythm in patients requiring heart surgery.
Keywords: Atrial Fibrillation. Arrhythmias, Cardiac. Ablation 
Techniques. Energy-Generating Resources. Cardiac Surgical 
Procedures.
INTRODUCTION
Atrial fibrillation (AF) is the most common and complex 
supraventricular arrhythmia with loss of atrial contraction, 
occurring in about 0.4% of the population and with 10% of the 
patients being over 60 years old. It is frequently associated with 
mitral valve disease and it is a constant cause of thromboembolic 
events, especially cerebrovascular[1].
There are several studies demonstrating that pharmacological 
means of controlling the rhythm does not reduce morbidity and 
mortality rate nor does it protect against thromboembolism. The 
AF that does not respond to medicines has several consequences 
such as maintaining the irregular rhythm (palpitations and 







= Atrial fibrillation 
= International Society of Minimally Invasive 
   Cardiothoracic Surgery 
= Latin American and Caribbean Health Sciences
= Medical Literature Analysis and Retrieval System Online
= Scientific Electronic Library Online 
= Saline-Irrigated Cooled-tip Radiofrequency Ablation 
DOI: 10.5935/1678-9741.20150078
1Universidade de Brasília (UNB), Brasília, DF, Brazil. 
2Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio 
Preto, SP, Brazil and Universidade de Campinas (UNICAMP), Campinas, SP, Brazil. 
This study was carried out at the Universidade de Brasilia Medical School (FM-




Universidade de Brasília (UNB) – Campus Darci Ribeiro
Av. L3 Norte, Asa Norte – Brasília, DF, Brazil – Zip code:70910-900
E-mail: avbrick@terra.com.br
Article received on September 8th, 2015
Article accepted on November 3rd, 2015
discomfort), loss of atrioventricular synchrony, heart failure, 
and atrial thrombosis with thromboembolic episodes, being 
the cause of stroke and pulmonary embolism in 33% of the 
cases[2-4]. Catheter ablation has an outstanding position in the 
treatment of AF, but surgery is an effective therapeutic method 
for treating chronic AF in patients who require heart surgery for 
other reasons.
The most accepted theory to explain the electrophysiological 
mechanism for maintenance of AF is multiple waves, described 
by Moe[5] and confirmed by the studies of Alessie et al.[6] and 
Cox et al.[7]. Subsequently, it was shown that AF is initiated 
by automatic foci with high triggering frequency[8,9]. The 
endocardial mapping revealed that these foci are located in the 
pulmonary veins and the creation of multi-shaped lesions with 
radiofrequency energy where foci originate interrupts AF[10]. 
While the cardiac electrical stimulation does not propagate 
where there is lesion with scarring, requiring normal myocardium 
to progress, the injury caused by ablation with energy sources 
interrupts the reentry circuit[8-10].
The International Consensus on Catheter Ablation for Atrial 
Fibrillation Surgery defined the following indications for surgical 
ablation of AF[11]: 1) symptomatic patients undergoing surgical 
procedures; 2) selected asymptomatic patients undergoing 
another surgical procedure in which ablation can be performed 
with minimal risk; and 3) surgery for primary AF, to be considered 
for symptomatic patients who opt for surgery in which one or 
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more attempts of catheter ablation have failed or who are not 
candidates for catheter ablation.
In addition, the Brazilian Guidelines for Treatment of AF 
indicate the following[12]: Class I: patients with symptomatic AF 
undergoing mitral valve surgery; Class II B: surgery for treatment 
of AF in patients with symptomatic AF in which catheter ablation 
cannot be performed or has failed.
The first non-pharmacological treatment of AF includes: 
1) electrical cardioversion with a high recurrence rate[13]; 2) 
techniques using intraoperative cryoablation of the bundle of 
His and the atrioventricular junction[14]; 3) isolation of the left 
atrium[15]; 4) catheter ablation of the atrioventricular junction 
and permanent pacemaker implantation[9]; 5) catheter ablation 
of the bundle of His and definitive pacemaker implant; and 6) 
“Corridor Operation[16]”.
Although they regularize heart rate, these procedures 
maintain the atria, or part of them, fibrillating, thereby not 
eliminating the risk of complications such as hemodynamic 
compromise and the occurrence of thromboembolic events.
Based on the electrophysiological mechanisms of AF 
analyzed in experimental studies, the “Cox operation” has been 
described, which consists of making incisions and sutures on the 
atrial wall, enabling the spread of electrical stimulation in the 
atria within a labyrinth, ordering atrial contraction[17]. Changes 
have been performed to the “Cox Operation”, making it simpler 
and also propitiating the return of sinusal rhythm[18]. Studies 
reporting the success of this technique were published, and it is 
considered the reference standard for the surgical treatment of 
AF[19,20], mainly in patients with mitral valve disease[21].
The wide dissection of cardiac structures and the 
extensive lines of section and suturing of the atrial wall, 
however, significantly increased operative time as well as 
cardiopulmonary bypass and aortic clamping time, resulting 
in higher postoperative morbidity and making the widespread 
application of the procedure difficult.
In order to increase the applicability and reduce the 
complexity of the “Cox operation”, several technical 
modifications were introduced, such as the change in the 
location of the atrial incisions[22]; the reduction of section lines 
and suturing of the atrial wall, known as “Mini Cox[23]”; and the 
unilateral procedure, performed only in the left atrium, called 
“Cox at Left”[24].
The use of catheter ablation for the treatment of 
supraventricular arrhythmias stimulated the use of energy 
sources (cryoablation, radiofrequency, microwave, ultrasound, 
and laser) to cause linear ablative lesions for endocardial and 
epicardial applications or to replace the cutting and suturing 
of the atrial wall[25-28], especially when associated with valvular 
disease.
The Maze I procedure developed by Cox employed section, 
suture, and cryoablation[19]. Changes in techniques, including the 
dismissal of cryoablation, have been introduced, such as described 
by Jazbik et al.[29], Gregori Jr. et al.[30], and Batista et al.[31].
Kalil et al.[32] performing a simplified surgical technique 
with a single incision around all four pulmonary vein ostia in 
patients with mitral valve disease, found that this technique was 
effective in treating AF secondary to mitral valve disease.
Several authors have developed and improved techniques 
to eliminate chronic AF and return to sinus rhythm in patients 
undergoing cardiac surgery, especially in patients with mitral 
valve disease, using various sources of energy capable of causing 
permanent blocking lines such as microwaves[33], ultrasound[34], 
cryoablation[23], radiofrequency[35], and laser[27].
Currently, the most widely used energy source is 
radiofrequency, an alternating current released in the form of 
an unmodulated, continuous sine wave capable of promoting 
ablation of the entire tissue. The wave can be either unipolar 
or bipolar, irrigated or not. The driving of the energy can 
be measured, demonstrating the transmural lesion, an 
important factor to eliminate arrhythmia[36]. After the use of 
radiofrequency as the form of energy most commonly applied 
in catheter ablation, results of experimental studies have been 
published[37,38] with new sources of energy being used in 
surgical ablation. Radiofrequency ablation for treatment of AF 
was described by Hindricks et al.[35].
Regarding cryoablation, there are two energy sources 
available: nitrogen oxides and argon, the difference being the 
ability to freeze the tissue. The size and depth of the lesion will 
depend on factors such as temperature of the ablation catheter, 
tissue temperature, size of the catheter, duration and number 
of ablation lines, and the type of source[20]. The disadvantage 
lies in the length of application and its limited use in minimally 
invasive techniques.
In an experimental study, Manasse et al.[39] used 
radiofrequency and cryoablation for endocardial and epicardial 
routes and/or video-assisted thoracoscopy, demonstrating 
the importance of the pulmonary veins and the presence of 
transmural lesions created quickly.
Microwave energy uses an electromagnetic field generated 
by oscillation of the tissue molecules, producing heat with 
uniform penetration and without burning the surrounding 
tissues[28]. There is also a limitation on its use in minimally 
invasive surgery, and complications and concerns about possible 
esophageal perforation.
The laser, despite being a promising form of energy, has 
been tested only in experimental studies[27].
The effects of ultrasound to treat AF are produced by 
tissue damage derived from hyperthermia in tissue necrosis, 
resulting in a transmural lesion that can be used in both 
endocardial and epicardial applications, in a minimally invasive 
manner. Considering the experience with the ultrasound scalpel 
(UltraCision®), often used in videolaparoscopic procedures[40] 
for treating refractory ventricular tachycardia, Brick et al.[26,41] 
devised a new approach to form lines of lesions, which would 
determine the partitioning of the left and right atria under 
shorter surgical and cardiopulmonary bypass time,  reflecting 
positively in postoperative complications.
The aim of this study is to present a literature review on 
surgical ablation of AF in patients undergoing cardiac surgery 
considering energy sources and return to sinus rhythm.
METHODS
This study was based on a review of the literature on chronic 
AF surgery using energy sources, available in the following 
databases: Latin American and Caribbean Health Sciences 
(LILACS), Medical Literature Analysis and Retrieval System Online 
(Medline), and Scientific Electronic Library Online (SciELO), in 
Portuguese and English, in the last 20 years. The keywords used 
included: atrial fibrillation, ablation techniques, energy sources, 
and results of surgical treatment.
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The analysis of the studies was performed descriptively in 
order to present current knowledge about surgical ablation of 
AF in patients undergoing cardiac surgery[42].
Experimental, randomized and non-randomized studies 
were analyzed on the development of surgical ablation of AF 
with energy sources associated with cardiac surgery.
Catheter ablation studies and surgical treatment of AF alone 
were excluded.
RESULTS
In this literature review, we identified 72 studies on evolution 
and improvement of surgery of arrhythmias, divided into: 
epidemiology and clinics (n=7), AF theories (n=4), guidelines 
(n=3), experimental surgery (n=9), pioneering surgery (n=8), 
section and suturing surgery (“Maze”) (n=16), and energy 
sources surgery (n=25) (Table 1).
Nineteen articles were identified from the first surgery to 
eliminate fibrillation, known as the Maze procedure pioneered 
by Cox, until the early use of energy sources for ablation of 
arrhythmia.
Regarding the use of energy sources, Table 2 presents 25 
articles focusing on sample size, type of study, results (early and 
late), and completion (percentage of return to sinus rhythm). 
Of those, six are randomized trials (484 patients), 17 are non-
randomized (1,551 patients), and two are meta-analyzes (74 
studies). A total of 19 studies were prospective; 4, retrospective.
Analyzing studies with immediate results (n=5), the 
percentage of return to sinus rhythm ranged from 73% to 96%, 
whereas in the long-term results (n=20) (from 12 months) the 
range was from 62% to 97.7%. In both, there was subsequent 
clinical improvement of patients who underwent ablation, 
regardless of the energy source used.
DISCUSSION
With research on the origin of AF and with the experience 
of electrophysiologists and surgeons, new approaches have 
emerged from the classic Maze surgery (Cox-Maze)[7,17,18], making 
the extensive manipulation of the atria inconvenient, with peri- 
and postoperative repercussions. Consequently, there has been 
a demand for less invasive procedures, such as manipulation 
only in the pulmonary veins and intraoperative ablation of atrial 
walls with alternative energy sources (cryoablation, microwave, 
radiofrequency, laser, and ultrasound), and thoracoscopy 
procedures using radiofrequency and ultrasound catheters from 
the epicardium in on-pump surgeries.
Atrial ablation can be performed using the traditional cut 
and suture technique as well as the simplified technique for 
pulmonary vein isolation, as demonstrated by Albrecht et al.[43] 
in a controlled, prospective randomized study.
In a prospective randomized study of patients with rheumatic 
mitral valve disease with chronic AF, Vasconcelos et al.[44] studied 
29 patients (n=13, control group; n=14, treated group) for 11.5 
months. The authors concluded that surgical isolation of the 
posterior wall of the left atrium involving the pulmonary vein 
ostia is an effective way of treating rheumatic mitral valvular 
disease in chronic AF.
Gomes et al.[45], using electrocautery in mitral valve surgery, 
found that this source of energy reversed arrhythmia in a 
significant number of patients. In the absence of ultrasound 
equipment, Brick (personal communication) had the opportunity 
to use electrocautery in a small number of patients, not 
recommending its routine use due to charring with the release 
of small emboli inside the atrium.
In the following paragraphs, the energy sources are reviewed 
with data from the literature.
In regard to cryoablation, Gallagher et al.[46] described its 
initial use in the treatment of accessory bundles as a method for 
correcting pre-excitation syndrome. Fukada et al.[47] investigated 
the indication of “Cox operation” in patients with mitral valve 
disease and AF using cryoablation to replace some of the atrial 
incisions. They observed that the ideal cases were patients with 
disease of non-rheumatic origin, especially those undergoing 
valve repair. 
Lee et al.[48] used cryoablation to replace the section and 
suture lines, dividing the patients into two groups: in the 
first one, the lines described in the “Cox operation” were 
used; in the second, the left and right pulmonary veins were 
isolated separately. Thus, they studied the improvement of 
atrial contraction in 83 patients undergoing surgical treatment 
of AF and other heart diseases. During early evolution and 
the six-month follow-up, it was demonstrated that the 
restoration of sinus rhythm and recovery of atrial contraction 
were significantly more evident in the second group. Later, 
Lee et al.[49] compared 86 patients with mitral valve disease 
of rheumatic origin to 43 patients with mitral disease of 
degenerative etiology and found similar results in both groups 
after six months, with conversion to sinus rhythm in 95.3% 
and 97.7% and recovery of atrial contraction in 90.4% and 
91.9%, respectively.
Cox et al.[50] described a minimally invasive technique for 
performing the “Cox operation III”, with access through right 
inframammary thoracotomy of about 7 cm, cannulation of 
artery, right femoral vein and superior vena cava for installation 
of cardiopulmonary bypass system and endocardial application 
of cryoablation to replace the section and suture lines.
In 2007, Blomström-Lundqvist et al.[51] stated the benefit 
of cryoablation in reversion and maintenance of sinus rhythm 
in patients undergoing mitral valve surgery. In a prospective 
multicenter randomized study, they analyzed 69 patients who 
Table 1. Classification of articles according to clinical and 
surgical characteristics.
Article N












Total of Selected Studies 72
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underwent mitral valve surgery with or without cryoablation 
in order to assess the efficacy of cryoablation applied to the 
epicardium of the left atrium in patients undergoing this type 
of surgery. During follow-up, heart rate was measured at 6 and 
12 months, sinus rhythm was regained in 73.3% of the patients 
who underwent ablation (in both periods) and in 45.7% (6 
months) and 42.9% (12 months) of patients who underwent 
mitral valve surgery alone. There was a significant difference 
between the groups in the two follow-up periods.
Johansson et al.[52] used epicardial cryoablation in a 
randomized study with 65 patients undergoing mitral valve 
surgery, concluding that the ablation group had better results.
This source of energy, originally used by Cox et al.[50], 
represents an effective and safe therapeutic option. However, 
the main drawback in minimally invasive surgery (off-pump) is 
that freezing the blood produces coagulation, resulting in the 
risk of thromboembolism[51].
Another source of energy, radiofrequency was the first 
alternative energy source applied in the surgical treatment of AF 
and it has been widely used. In point-by-point radiofrequency 
ablation, the irrigated unipolar device produces linear tissue 
lesions. A bipolar catheter is able to promote ablation of all 
tissue involved by the electrodes quickly (usually less than 
10 seconds). Breda et al.[53] reported the initial assessment of 
surgical biatrial ablation by radiofrequency. Energy output can 
be measured during ablation and this can be correlated with 
proven transmural lesions[54].
In 2008, Beukema et al.[55] published the results of medium- 
and long-term follow-up after radiofrequency ablation 
associated with other cardiac surgeries and demonstrated 
Table 2. Summary of literature on surgery of chronic atrial fibrillation using energy sources.
Author / Year
Energy Source / 
Reference




Breda et al./2010 53 15 Prospective Immediate 96.0
Beukema et al./2008 55 258 Retrospective Late 69.0
Williams et al./2001 56 48 Prospective Late 81.0
Kottkamp et al./2002 57 70 Prospective Late 93.0
Benussi et al./2002 58 132 Prospective Late 76.9
Canale et al./2011 59 53 Retrospective Late 68.0
Canale et al./2011 60 47 Prospective Immediate 73.0
Huang et al./2014 61 81 Retrospective Late 76.0
Dong et al./2013 62 191 Retrospective Late 79.1
Phan et al./2014 63 62 Meta-analysis randomized controlled trials Late 67.9
Colafranceschi et al./2009 64 10 Prospective Immediate 80.0
Abreu Filho et al./2005 65 70 Prospective randomized Late 79.4
Ultrasound
Brick et al./2001 68 27 Prospective Immediate 81.4
Ninet et al./2005 69 103 Prospective Late 85.0
Lins et al./2010 70 44 Prospective randomized Late 86.4
Groh et al./2008 71 98 Prospective Late 84.0
Cryoablation
Fukada et al./1998 47 29 Prospective Late 65.5
Lee et al./2001 48 83 Prospective randomized Late 95.7
Lee et al./2003 49 129 Prospective randomized Late 97.7
Blomström-Lundqvist et al./2007 51 69 Prospective randomized double-blind Late 73.3
Johansson et al./2012 52 65 Randomized Late 73.0
Microwave
Gillinov et al./2002 28 20 Prospective Immediate 75.0




Lin et al./2011 67 94 Prospective randomized Late 87.0
Electrocautery
Gomes et al./2008 45 23 Prospective Late 76.4
*Late results correspond to those obtained from 6 months of follow-up
**Percentage of return to sinus rhythm
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maintenance of sinus rhythm in 69% of the cases treated in 
the 1-year follow-up, 56% in 3 years, 52% in five years, and 
57% in later periods. Treatment with antiarrhythmic drugs was 
maintained in 64% of the patients who were free of AF; only 
1% was under oral anticoagulation regimen.
Williams et al.[56] described the experience of three centers 
with the use of flexible catheter for applying radiofrequency 
in pulmonary vein isolation using the endocardial application, 
similar to the “Cox operation”, or separately in the right and 
left sides, with lesions communicating between the two blocs. 
The procedure was performed in 48 patients undergoing 
other associated procedures and, in eight cases, lesions were 
performed in the right atrium. Results showed survival rates of 
87.5% and restoration of sinus rhythm in 81% of the cases at 
an average follow-up of four months.
Kottkamp et al.[57], through access with anterolateral right 
mini-thoracotomy and video-assisted cardiopulmonary bypass, 
performed continuous linear lesions with endocardial application 
of radiofrequency in the left atrium, involving the mitral annulus 
and the pulmonary veins after anatomical definition of reentrant 
circuits with electrophysiological mapping. The procedure was 
performed in 70 patients with persistent or paroxysmal AF. After 
six months, 93% of patients were in sinus rhythm; after 12 
months, 95% of patients had persistent AF and 97% of patients 
with paroxysmal AF were in sinus rhythm. Complications from 
the procedure are a case of esophageal perforation and a case 
of development of circumflex coronary artery stenosis.
Benussi et al.[58] described the epicardial application of 
radiofrequency with multipolar catheter for performing 
lesions in 40 patients with mitral valve disease. The procedure 
was performed around the right and left pulmonary veins, 
connecting them to the left atrial appendage. After the left 
atriotomy, endocardial application joined the lesions of the 
pulmonary veins with the mitral valve, with the exclusion, in 
the end, of the left atrial appendage. In the mean follow-up 
of 11.6 months, 76.9% of the patients had reverted to sinus 
rhythm, with a significant reduction in the diameter of the left 
atrium and recovery of right and left atrial contraction. In the 
medium-term, the results of the experience with radiofrequency 
ablation for AF in 132 patients were presented, being performed 
through epicardial application in 107 patients. The lesions in 
the left atrium were performed prior to cardiopulmonary bypass 
and used for correction of associated heart diseases. Operative 
mortality was 0.8%. After three years of development, 77% of 
the patients were free of AF and 98% were free of stroke, with 
a survival rate of 94%.
In 2011, Canale et al.[59,60] performed retrospective studies 
demonstrating that the use of bipolar radiofrequency led to the 
reversal of arrhythmia in 68% of the patients after 14 months 
in one of the studies and in 73% of the patients in the period of 
7 months according to the other one. The author’s experience 
with the use of bipolar radiofrequency was more efficient than 
with unipolar. In 2014, Huang et al.[61], after comparing the use 
of monopolar and bipolar radiofrequency, concluded that both 
are effective for the treatment of chronic AF, however, ablation 
with bipolar radiofrequency is more convenient.
Dong et al.[62], in 2013, analyzed concomitant valve 
replacement and radiofrequency ablation in 191 patients with 
rheumatic disease; 158 patients were followed-up for a year 
and sinus rhythm was maintained in 79.11%.
In 2014, Phan et al.[63], after performing cumulative meta-
analysis of randomized clinical trials of surgeries with and without 
AF ablation in six databases, identified sixteen randomized trials 
and concluded that surgical ablation concomitant with cardiac 
surgery was effective and safe to restore sinus rhythm, after 12 
months of follow-up.
Colafranceschi et al.[64] performed video-assisted 
thoracoscopic surgery in 2009, concluding that it is safe and 
reproducible, especially in patients with paroxysmal fibrillation 
refractory to drug therapy who did not require concomitant 
surgery. This technique opens new paths for patients who have 
not responded adequately to catheter treatment.
In Brazil, Brick et al.[26] started to experience with a unipolar 
radiofrequency catheter while performing point-by-point 
ablation of the left atrium. The development of bipolar ablation 
devices with irrigated catheter contributed to the technical 
improvement of the procedure, leading to shorter operative 
time and postoperative results showing a satisfactory success 
rate of 96% of sinus rhythm reversal[53].
Abreu Filho et al.[65] evaluated 70 patients with permanent 
AF and rheumatic mitral valve disease. These patients were 
randomly assigned to undergo either a modified Maze III 
procedure using Saline-Irrigated Cooled-tip Radiofrequency 
Ablation (SICTRA) associated with mitral valve surgery (group 
A) or mitral valve surgery alone (group B). The cumulative rates 
of sinus rhythm were 79.4% in group A and 26.9% in group B 
(P=0.001). They concluded that SICTRA is effective for treating 
permanent AF associated with rheumatic mitral valve disease.
Using microwave as an energy source, Gillinov et al.[28] 
described their experience with ablation in 10 patients 
undergoing surgery for mitral valve and pulmonary vein isolation 
for epicardial application. After opening the left atrium, the 
lesions were observed from the endocardial surface, proving to 
be transmural.
In 2012, MacDonald et al.[66] concluded that microwave 
energy concomitant with surgery was not as effective when 
compared to radiofrequency ablation in long-term outcome 
assessment.
Lin et al.[67], in 2011, compared the use of microwave in 
94 patients to the use of bipolar radiofrequency in 93 patients 
undergoing valve surgery, for three months, concluding that 
radiofrequency ablation is superior to ablation with microwave.
The use of ultrasound in the treatment of AF promotes 
tissue damage by hyperthermia. This technology is attracting 
interest because it allows for ablation in a less invasive manner, 
without damaging adjacent structures. Brick et al.[68] began 
their experience with ultrasound using the unipolar endocardial 
catheter ablation and three patients underwent surgery with 
reversion to sinus rhythm.
Execution of intraoperative ablation using this technique, in 
addition to facilitating and reducing the operative time, allowed 
for greater understanding of the role of the left atrium and 
pulmonary veins in chronic fibrillation[26,37].
Additional procedures were performed, such as exclusion of 
the right and left atrial appendages; reduction of the left atrium, 
where necessary; and ablation of the right atrium to eliminate 
the possibility of atrial flutter.
Ninet et al.[69], in a multicenter study, prospectively analyzed 
103 patients between September 2002 and February 2004, 
using ultrasound for epicardial ablation of AF. Ablation was 
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performed through epicardial application using a high-frequency 
ultrasound, EpiCor® (St Jude Medical Inc). Analysis showed that, 
after six months, 85% of patients were in sinus rhythm. They 
demonstrated the advantage of using the energy of ultrasound, 
creating a transmural lesion around the left atrium without the 
use of cardiopulmonary bypass.
Lins et al.[70] showed an improvement in functional class in 
the treated group versus the control group in a comparative 
study of patients with mitral valve disease, using ultrasound 
scalpel (UltraCision®). The groups presented homogeneous 
preoperative characteristics and no significant difference 
considering cardiopulmonary bypass times, anoxia and 
postoperative intensive care unit stay, which leads to the 
conclusion that the use of ultrasonic scalpel for AF ablation 
does not act to worsen patient outcomes. Comparing patients 
who underwent ultrasound ablation with those who received 
no recent ultrasound ablation, no more complications or deaths 
in recent or late postoperative were found. The results observed 
in this study show that the ultrasound ablation technique can 
be applied to patients who have surgical indication for mitral 
valve disease correction.
In addition to the endocardial application, ultrasound with 
other devices such as the EpiCor® can be used in off-pump 
surgery, through epicardial application in patients with isolated 
fibrillation, as well as in patients with ischemic heart disease 
undergoing coronary artery bypass graft surgery[71]. 
The objective of the 2009 Consensus Conference of the 
International Society of Minimally Invasive Cardiothoracic 
Surgery (ISMICS)[72] was to determine whether surgical 
ablation of AF during associated cardiac procedures improved 
postoperative clinical outcomes. The group involved in the 
study analyzed the best available evidence, with systematic data 
review, including randomized and non-randomized controlled 
studies, always in descending order of importance. A systematic 
review and meta-analysis identified 10 randomized trials (650 
patients) and 23 non-randomized (3997 patients); the great 
majority was published in English and performed in the United 
States.
The authors of the consensus defined the following 
recommendation: in patients with persistent and permanent AF, 
surgical ablation is recommended to increase the incidence of 
sinus rhythm in the short- and long-term (Class 1, Level A); reduce 
the risk of stroke and thromboembolic events (Class 2a, level 
A); increase exercise tolerance and improve ventricular function 
(Class 2a, level A); and increase survival (Class 2a, level B)[72].
 
CONCLUSION
Evolving from the classical labyrinth surgery (Cox-Maze), 
changes in demand for less invasive procedures have occurred 
with the use of alternative sources of energy.
The results of the surgical ablation of AF in patients 
undergoing cardiac surgery depend on the energy source used; 
the lesion produced is transmural and applied in both atria.
We conclude that surgical ablation of AF is essential in the 
treatment of this arrhythmia. With current technology, it may be 
minimally invasive, making it mandatory to perform a procedure 
in an attempt to revert to sinus rhythm in patients requiring 
heart surgery.
Situations involving primary fibrillation surgery indication 
should include a multidisciplinary team approach involving 
cardiologists, electrophysiologists and surgeons to make the 
correct choice of patients and the most appropriate procedure.
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